NCIt definition : A preparation of cytotoxic T-lymphocytes (CTL), specifically reactive to the Epstein-Barr
virus (EBV) latent membrane proteins (LMP) 1 and 2, with potential antineoplastic
activity. Autologous dendritic cells and EBV-infected lymphoblastoid cell lines (LCL)
from patients with EBV-positive nasopharyngeal carcinoma (NPC) are transduced with
an LMP1/LMP2-expressing adenoviral vector, are irradiated, and then are used to stimulate
and expand autologous CTL to produce autologous LMP1-/LMP2-specific CTL ex vivo. Administration
of autologous LMP1-/LMP2- specific cytotoxic T-lymphocytes may result in a specific
CTL response against tumor cells expressing LMP1 and LMP2, resulting in cell lysis
and inhibition of tumor cell proliferation in vivo. Among a limited set of viral antigens
expressed by NPC cells, LMP1 and LMP2 are weak immunogens which, nevertheless, are
capable of inducing a T-lymphocyte response.;